DENTSPLY SIRONA Inc. (XRAY) Holdings Reduced by Elk Creek Partners LLC

Elk Creek Partners LLC lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,891 shares of the medical instruments supplier’s stock after selling 696 shares during the quarter. Elk Creek Partners LLC’s holdings in DENTSPLY SIRONA were worth $317,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in XRAY. Alps Advisors Inc. raised its stake in shares of DENTSPLY SIRONA by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after buying an additional 20 shares during the last quarter. Wetherby Asset Management Inc. raised its stake in shares of DENTSPLY SIRONA by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after buying an additional 30 shares during the last quarter. HighTower Advisors LLC raised its stake in shares of DENTSPLY SIRONA by 0.6% during the 1st quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock worth $424,000 after buying an additional 39 shares during the last quarter. Atria Investments LLC raised its stake in shares of DENTSPLY SIRONA by 1.5% during the 2nd quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock worth $294,000 after buying an additional 68 shares during the last quarter. Finally, Advantus Capital Management Inc raised its stake in shares of DENTSPLY SIRONA by 0.4% during the 1st quarter. Advantus Capital Management Inc now owns 22,995 shares of the medical instruments supplier’s stock worth $1,436,000 after buying an additional 100 shares during the last quarter. 93.87% of the stock is owned by institutional investors.

XRAY has been the subject of several research reports. Goldman Sachs Group, Inc. (The) downgraded DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and cut their price target for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target for the company. Finally, Credit Suisse Group reaffirmed an “outperform” rating and set a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company’s stock. DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $65.73.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Holdings Reduced by Elk Creek Partners LLC” was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/09/19/dentsply-sirona-inc-xray-holdings-reduced-by-elk-creek-partners-llc.html.

DENTSPLY SIRONA Inc. (XRAY) opened at 58.36 on Tuesday. The company has a 50-day moving average of $57.10 and a 200 day moving average of $61.71. DENTSPLY SIRONA Inc. has a 52 week low of $52.54 and a 52 week high of $65.68. The firm’s market cap is $13.39 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same period in the prior year, the business posted $0.76 earnings per share. DENTSPLY SIRONA’s revenue was down 2.9% compared to the same quarter last year. On average, equities analysts predict that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.60%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is -10.09%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply